Literature DB >> 1790263

Increased insulin levels after OGTT load in peripheral blood and cerebrospinal fluid of patients with dementia of Alzheimer type.

Y Fujisawa1, K Sasaki, K Akiyama.   

Abstract

An investigation was carried out to determine whether a disturbance of glycometabolism is associated with dementia of Alzheimer type (AD). The first part of the study was carried out on 108 AD patients and 57 normal controls (NCs). Neither the plasma level of insulin nor that of glucose differed significantly between the two groups before the oral glucose tolerance test (OGTT), whereas there was a significantly greater increase of the plasma insulin in the AD group than in the NC group after the OGTT. The second part of the study was carried out on 54 AD patients, 44 patients with vascular dementia (VD), and 26 NCs. Early in the morning after overnight fasting, there was no significant difference in the fasting plasma level of either glucose or insulin, or the cerebrospinal fluid (CSF) level of glucose, among the three groups, However, the CSF level of insulin was significantly higher in the AD group than in the other two groups. These results suggest that an abnormally high level of insulin, not only in the peripheral blood after OGTT load but also in the CSF after fasting, may be associated with the pathology of AD.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1790263     DOI: 10.1016/0006-3223(91)90158-i

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  31 in total

1.  Aging-related correlation of insulin-degrading enzyme with gamma-secretase-generated products involving insulin and glucose levels in transgenic mice.

Authors:  Dae Y Hwang; Jung S Cho; Chuel K Kim; Sun B Shim; Seung W Jee; Su H Lee; Su J Seo; Joon Y Cho; Seok H Lee; Yong K Kim
Journal:  Neurochem Res       Date:  2005-09       Impact factor: 3.996

Review 2.  Metabolic derangements mediate cognitive impairment and Alzheimer's disease: role of peripheral insulin-resistance diseases.

Authors:  S M De La Monte
Journal:  Panminerva Med       Date:  2012-09       Impact factor: 5.197

3.  The Effects of Peripheral and Central High Insulin on Brain Insulin Signaling and Amyloid-β in Young and Old APP/PS1 Mice.

Authors:  Molly Stanley; Shannon L Macauley; Emily E Caesar; Lauren J Koscal; Will Moritz; Grace O Robinson; Joseph Roh; Jennifer Keyser; Hong Jiang; David M Holtzman
Journal:  J Neurosci       Date:  2016-11-16       Impact factor: 6.167

4.  Association of plasma β-amyloid 40 and 42 concentration with type 2 diabetes among Chinese adults.

Authors:  Xiaobo Peng; Zihui Xu; Xiaoxing Mo; Qianqian Guo; Jiawei Yin; Mengdai Xu; Zhao Peng; Taoping Sun; Li Zhou; Xiaolin Peng; Shufang Xu; Wei Yang; Wei Bao; Zhilei Shan; Xiaoqin Li; Liegang Liu
Journal:  Diabetologia       Date:  2020-02-07       Impact factor: 10.122

5.  Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes.

Authors:  Shuko Takeda; Naoyuki Sato; Kozue Uchio-Yamada; Kyoko Sawada; Takanori Kunieda; Daisuke Takeuchi; Hitomi Kurinami; Mitsuru Shinohara; Hiromi Rakugi; Ryuichi Morishita
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

6.  Propionibacterium acnes in the cortex of patients with Alzheimer's disease.

Authors:  H H Kornhuber
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

7.  Nerve growth factor receptor TrkA, a new receptor in insulin signaling pathway in PC12 cells.

Authors:  Thangiah Geetha; Shraddha D Rege; Salome E Mathews; Susan O Meakin; Morris F White; Jeganathan Ramesh Babu
Journal:  J Biol Chem       Date:  2013-06-07       Impact factor: 5.157

Review 8.  The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease.

Authors:  Konrad Talbot; Hoau-Yan Wang
Journal:  Alzheimers Dement       Date:  2014-02       Impact factor: 21.566

Review 9.  Intranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the art.

Authors:  Suzanne M de la Monte
Journal:  Expert Opin Drug Deliv       Date:  2013-11-12       Impact factor: 6.648

Review 10.  Alzheimer's disease and insulin resistance: translating basic science into clinical applications.

Authors:  Fernanda G De Felice
Journal:  J Clin Invest       Date:  2013-02-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.